DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Referenz

Zheng SL, Roddick AJ, Aghar-Jaffar R. et al.
Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis.

JAMA 2018;
319: 1580-1591.
DOI: 10.1001/jama.2018.3024.

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: